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Abstract 
Introduction: 
Reports on intraocular pressure (IOP) changes at high altitudes have revealed inconsistent and 
even conflicting results. The aim of this study was to investigate the effect of very high altitude 
and different ascent profiles on IOP in relation to simultaneously occurring ophthalmic and 
systemic changes in a prospective study.  
Methods:  
Prospective study in 25 healthy mountaineers who were randomly assigned to two different 
ascent profiles during a medical research expedition to Mt Muztagh Ata (7546m/24751ft). Group 
1 was allotted a shorter acclimatization time prior to ascent than Group 2. Besides IOP, oxygen 
saturation (SaO2), acute mountain sickness symptoms (AMS-c score) and optic disc appearance 
were also assessed. Examinations were performed at 490m/1607ft, 4497m/14750ft, 
5533m/18148ft and 6265m/20549ft above sea level.  
Results:  
Intraocular pressure in both groups showed small but statistically significant changes: an increase 
during ascent from 490m/1607ft to 5533m/18148ft and then a continuous decrease during further 
ascent to 6265m/20549ft and upon descent to 4497m/14750ft and to 490m. Differences between 
groups were not significant. Multiple regression analysis (IOP dependent variable) revealed 
significant partial correlation coefficient of Beta= -0.25 (p=0.01) for SaO2,and Beta = -0.23 
(p=0.02) for acclimatization time. 
Discussion:  
Hypobaric hypoxia at very high altitude leads to small but statistically significant changes in IOP 
that are modulated by systemic oxygen saturation and correlate with optic disc swelling. Climbs 
to very high altitudes seem to be safe with regard to intraocular pressure changes. 
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Introduction 
Traveling to high altitudes for recreational reasons is becoming increasingly popular and has 
been a subject of scientific interest ever since.  Technical progress enables researchers to gain 
new insights into changes that occur within the human body upon exposure to natural hypobaric 
atmospheric conditions.  
Intraocular pressure (IOP) changes at high altitudes have been the subject of several publications 
1-9
. Yet results have been inconsistent. Findings range from a decrease 1, 4, 6, 8, 9 through 
unchanged 5, to an increase 1 in IOP at moderate to high altitudes. Changes in intraocular 
pressure during an expedition to very high altitudes, i.e. more than 5500m/18045ft, have not 
been documented yet. 
Depending on the degree of hypoxia 10, ascent rate 11 and individual susceptibility 12, acute 
mountain sickness or even the less common high altitude cerebral edema (HACE) may occur. 
HACE results in increased intracerebral pressure (ICP) and hence in cerebral hypoperfusion with 
possible severe and fatal dysfunction13. Several studies suggest that a rise in ICP leads to an 
increase in IOP, and thus that IOP measurement could be a minimally invasive method to detect 
a rise in ICP 14-16. Therefore, a correlation of IOP with parameters indicating cerebral affection 
due to hypoxia would be of great interest.  
The Muztagh Ata medical research expedition study included researchers from various medical 
specialties, such as pneumology, neurology, hematology and ophthalmology, in a holistic 
approach to prospectively assess hypoxia induced changes of the body. A list of the discipline 
specific studies along with references can be found in Table 1. We set out to investigate changes 
in IOP at very high altitudes (>6000m/19685ft) with two different ascent profiles and place these 
results into perspective with simultaneously occurring ophthalmic and systemic changes (e.g. 
optic disc status, cerebral acute mountain sickness scores including possible HACE, pulse 
oximetry).
Page 4 of 23IOVS
Methods 
Our working hypothesis was that IOP would decrease with altitude due to lower systemic oxygen 
saturation and decreased aqueous production. 
Volunteers  
This randomized, prospective, multidisciplinary, observational cohort study 17-20 was performed 
within the scope of a high altitude medical research expedition on Mt. Muztagh Ata 
(7546m/24751 ft), Fig. 1. Mountaineers in good physical shape were included. Exclusion criteria 
were any type of ocular, cardiac or respiratory disease or history of high altitude pulmonary 
edema or high-altitude cerebral edema, history of ophthalmic disease or ophthalmic surgery 
(including cataract), contact lens wearers and intake of drugs other than non-steroidal 
antirheumatic agents during the expedition. The study was approved by the Ethical Committee of 
the University Hospital, Zurich, and adheres to the tenets of the Declaration of Helsinki (1983 
revision). Informed, written consent was obtained from all subjects prior to the examinations. 
 
Ascent profile 
For security reasons and in order to study the effect of acclimatization, the participants were 
randomly distributed into two groups with different ascent profiles (Fig. 2). The average ascent 
rate was 190 and 200 m/d (623 and 656ft/d), for group 1 and group 2 respectively. The climb 
began at 3750m (12300ft) in a village called Subash and progressed to base camp (BC = 
4497m/14750ft), camp 1 (C1 = 5533m/18148ft), camp 2 (C2 = 6265m/ 20549ft), camp 3 (C3 = 
6865m/22517ft) and to the summit (7546m/24751ft) within 20 (group 1) and 19 (group 2) days.  
 
Measurements  
All participants underwent general and ophthalmic baseline examinations one month prior to the 
expedition (ZH) at the University Hospital of Zurich, Switzerland, (490m/1607ft). At the time of 
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the expedition, examinations were performed during the ascent on the subsequent day upon 
arrival at each new high camp, i.e. from BC to C2, and at return to base camp (BC2). Each 
mountaineer had to have reached at least C2 to be included in the evaluation. 
Intraocular pressure (IOP) was measured with the Tono-Pen XL (Reichert, Inc., Depew, NY 
USA) by placing the tip of the device onto the central cornea after local anesthesia with 
oxybuprocaine 0.4% SDU Faure (Novartis Pharma AG, Basel, Switzerland).  Three complete 
measurements were taken; the average was calculated and recorded. All three readings used for 
calculating the average were required to have a standard deviation of  5%, as shown on the 
instrument’s digital display. The tonometer was calibrated prior to each examination session 
according to the manufacture’s guidelines.  
Central corneal thickness (CCT) measurements during the expedition20 were performed with the 
Pocket II Precision pachymeter (QUANTEL MEDICAL, Clermont-Ferrand, France) after IOP 
measurements. CCT was determined in micrometers (m) by averaging 5 successive readings in 
each eye.  A maximum standard deviation of 15m was defined a priori, and if this was 
exceeded, the complete measurement was repeated.   
Fundus photographs were acquired using a handheld digital fundus camera (Genesis-D, Kowa 
Inc., Tokyo, Japan). Photographs were analyzed by three independent ophthalmologists. Optic 
discs were graded being either not swollen, equivocal, or swollen17. 
Measurements were performed after one night of acclimatization19 at similar times of day in 
order to minimize the effect of strenuous exercise 21 and diurnal variation 22.  
Cerebral acute mountain sickness (AMS-c) scores on the Environmental Symptoms 
Questionnaire III 23 were assessed daily during the expedition. The AMS-c score represents 
symptoms that seem to reflect altered cerebral function. A score of 0.7 or greater reliably 
identifies a person with AMS. It pertains to items including light-headedness, headache, 
dizziness, dim vision, off-coordination, gastrointestinal tract upset, and weakness. The score is 
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calculated by the sum of all item scores (range, 0-5) multiplied by their respective factorial 
weight and then multiplied by 0.1927. 
Daily pulse oximetry was performed in the evening during quiet rest in a standing position with a 
finger pulse oximeter (Onyx 9500 SportStat, Nonin Medical Inc., Plymouth, MN, U.S.A.). Stable 
values after at least 3 minutes were recorded. Temperature was measured using a digital 
thermometer in the examination tent. 
Statistical analysis 
Statistical analysis was performed with commercially available statistical software packages 
(SPSS 13, SPSS Inc., Chicago, IL, USA and Statistica 6, Statsoft INC, Tulsa, OK). Test for 
normal distribution was performed using the Kolmogorov-Smirnov test. Measurements at each 
altitude between the two groups were compared using the unpaired Student’s t-test (inlcuding 
Welch-correction). Repeated measures analysis of variance (ANOVA) was performed with 
combined data of groups 1 and 2 to assess changes in IOP over the different altitudes. 
Assumption of sphericity was assessed using Mauchly’s test. In case of a statistically significant 
result, post-hoc testing with Bonferroni’s correction was applied.  
Multiple regression analysis was used to analyze correlations between IOP as the dependent 
variable and independent variables (ascent group and different times of acclimatization, SaO2, 
cerebral acute mountain sickness (AMS-c) score, central corneal thickness (CCT), altitude, optic 
disc appearance) and age. The time of acclimatization was defined as the amount of days during 
the expedition starting from Subash. Correlation between environmental temperature and IOP as 
well as pachymetry and IOP was analyzed using bivariate regression analysis. Normally 
distributed data are presented as mean ± standard deviation (SD), not-normally distributed data 
are expressed as median and range (minimum and maximum). A two sided -error (p-value) of 
less than 0.05 was considered statistically significant. 
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Results 
Seven out of a total of 32 climbers included in the ophthalmic branch of the study were excluded 
because of either incomplete data collection during the expedition (n=4), a history of refractive 
surgery on both eyes (LASIK, n=1) or due to drug intake during the examination period (n=2). 
Of the 25 climbers included, 5 were female and 20 male. Mean age in groups 1 and 2 were 
42±12 years and 45±9 years, respectively, without a significant difference between groups 
(p=0.54). 17 mountaineers (9 in group 1 (Gr1), 8 in group 2 (Gr2)) reached the summit. 
Intraocular pressures in both ascent groups increased from ZH to C1 and then continuously 
decreased while further ascending to C2, re-descending to BC2 as shown in Table 2. Maximum 
IOP measurements never exceeded 21mmHg in both groups. Due to logistic reasons, group 1 
could not be examined at BC2. No significant differences between ascent groups were found at 
any altitude (ZH p=0.78, BC1 p=0.77, C1 p=0.65, C2 p=0.82). Thus for further analyses, 
measurements of both groups were combined. Mean IOP changes for both groups are shown in 
Fig. 3.  ANOVA revealed a significant IOP*altitude interaction (p=0.01). The significant 
differences between IOP values at each altitude found in post-hoc testing are illustrated in Fig.  
3.  
Central corneal thickness increased from 537 to 572 m in group 1 and from 534 to 563 m in 
group 2 with increasing altitude and decreased after decent20. Oxygen saturation (SaO2) 
measurements, and AMS-c scores are shown in Table 3. IOP measurements were undertaken in 
the same windless tent with temperatures varying from 9° (minimum temperature at C2) to 37° 
(maximum temperature at BC) Celsius during the day with a mean of 21°C±7. 
Multiple regression analysis with IOP as the dependent variable revealed a partial correlation 
coefficient of Beta= -0.25 (p=0.01) for SaO2, -0.23 (p=0.02) for acclimatization time, -0.11 
(p=0.18) for ascent group, 0.02 (p=0.85) for AMS-c score, -0.09 (p=0.32) for optic disc swelling, 
and 0.13 (p=0.13) for age. No multicollinearity was detected. No statistically significant 
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correlation between environmental temperature and IOP values were found (ZH r=0.16 p=0.26, 
BC1 r=-0.18 p=0.20, C1 r=0.17 p=0.24, C2 r=-0.10 p=0.49, BC2 r=-0.21 p=0.32). Analysis 
testing for a correlation between pachymetry and IOP at each altitude did not reveal significant 
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Discussion 
This study reveals two main findings: Firstly, only small but statistically significant changes in 
intraocular pressure (IOP) over time were found during an expedition to very high altitudes. 
Secondly, IOP correlated with oxygen saturation at various altitudes.  
Our findings for the initial but statistically insignificant increase in IOP at 4497m/14750ft 
parallel the results of Somner et al. 1. Thereafter, the decline in IOP at further ascent to higher 
altitudes (at 6265m/20549ft), at which severe systemic hypoxia occurs, may be due to depleted 
oxygen supply to the non-pigmented ciliary epithelium and hence to decreased aqueous humor 
production. Aqueous production seems to become impaired after a certain systemic hypoxia 
threshold has been reached, which is supported by the statistically significant negative 
correlation between oxygen saturation in the participants at various heights and their IOP. The 
pathophysiology behind this phenomenon may be comparable to that reported in other conditions 
with impaired oxygen supply to the ciliary body such as  in ocular ischemic syndrome 24. or in 
severe cases of giant cell arteritis25.  
The rationale behind randomizing the climbers into two groups with different ascent profiles was 
to assess differences in the measured parameters which may have been due to distinct 
acclimatization times. Safety reasons also played a role in keeping the ascent groups limited. 
Duration between examinations at BC1 and C2 was seven days in group 1 and eleven days in 
group 2 (see Fig. 2). As no significant differences in the IOP values in the ascent groups were 
found, the differences in acclimatization time might have been too little to detect IOP behavior 
changes between the two groups. IOP reduction over time did occur, however, and a significant 
negative correlation between acclimatization time and IOP measurements was found in our 
analysis. Pressures at BC2 (4497m), 13 days after having climbed to substantially higher 
altitudes following the initial measurements, were significantly lower than the ones at the same 
altitude (BC1). Thus, hypoxia during a prolonged stay at high altitudes may also lead to reduced 
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aqueous production and therefore to the decline in intraocular pressure measured at 6250m (C2) 
1, 26
. But overall, the duration of systemic hypoxia seems to play a greater role in IOP reduction 
compared to the extent of hypoxia. Yet, from the current data, no estimation can be made upon 
the amount of contribution of acclimatization towards IOP reduction. 
No statistically significant correlation was found between IOP and optic disc swelling or AMS-c 
scores.  As reported earlier 27, a high incidence of optic disc swelling has been observed in more 
than half of our volunteers with increasing altitude, representing increasingly severe hypoxia. All 
evidence pointed towards hypoxia-induced increase in brain volume as the most probable 
etiology of the optic disc swelling, with a potential consecutive increase in intracranial pressure 
(ICP). Several studies support the hypothesis that a rise in ICP leads to an increase in IOP. Thus 
IOP measurement could be used as a minimally invasive method to detect a raise in ICP 14-16. 
Other investigators 28, 29, found no correlation between IOP and optic disc swelling, i.e. a rise in 
ICP. Nevertheless, due to the small changes in IOP noted at different altitudes, which were 
clinically insignificant, we suggest that measuring the IOP in climbers at high altitudes is not an 
appropriate method to detect an increase in ICP. 
In addition, acute strenuous exercise is known to lower the IOP 21. However, 10 minutes after 
stopping the exercise, Price et al. detected no significant IOP difference to baseline data21. Our 
participants were examined on the day following ascent to a new high camp, thus allowing for at 
least 15 hours of rest. Based on the study design with moderate ascent rate, the influence of 
physical exercise should have been minimal on all our measured parameters.  
IOP readings are largely influenced by mechanical properties of the eye. These properties may 
be altered by the development of corneal edema and are neither linear nor measurable to date 30, 
31
. Previous reports indicate a greater accuracy in IOP measurements by the TonopenXL on 
edematous corneas 32-34. In normal corneas, the TonoPenXL has been shown to be least affected 
by CCT when comparing it to other transportable handheld tonometers 35. Due to its portability 
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and ease of use, we chose the lightweight TonopenXL for our expedition. Concerning 
temperature variations during the expedition, especially low temperatures that may decrease 
battery voltage output, the manual of the Tonopen XL explicitely states, that in the event of low 
battery output, the diplay shows the letters “LoB”. In the situation of low temperature, that may 
affect the transducer, the device may be inactivated or the calibration process may be slowed 
down. During our expedition, no such events occurred.  
 
Measuring IOP in such conditions as in a low temperature environment, can alter the 
measurement results by causing a decrease in episcleral venous pressure 36. There was no 
correlation between temperature and IOP measurements at any altitude in this study. 
As shown in our study, changes in IOP during very high altitude mountaineering are small and 
insignificant from a clinical point of view, which is in conjunction with previous studies. In 
essence, exposure to very high altitudes results in a slight decrease in IOP.  Considering our data 
from the highest IOP examinations to date, in addition to already existing data, we conclude that 
measuring the IOP is not a useful screening method for incipient and potentially harmful 
altitude-dependent diseases. In summary, in healthy persons climbs to very high altitudes seem 
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Table 1 : Overview of the of the discipline specific studies. The first column denotes the 
discipline, the second column the title of the studies performed and the third column lists the 
respective reference.  
Table 1: High altitude medical research expedition to Mt Muztagh Ata 2005  
   
Discipline Discipline-specific studies References (partially to be found in the 
manuscript text) 
   
Ophthalmology Incidence of optic disc swelling at very high altitudes Arch Ophthalmol 2008, Ref. 13 
 Effect of high altitude on ocular blood flow J Appl Physiol 2009, Ref 14 
 Effect of high altitude on corneal thickness in healthy 
mountaineers 
Arch Ophthalmol, in press, Ref 16 
 Incidence of retinal hemorrhages and their implications 
during a high altitude climb 
Manuscript submitted 
 Effect of high altitude on corneal topography Manuscript in preparation 
   
Internat Medicine 
and Pneumology 
Effect of ascent protocol on acute mountain sickness: : 
Randomized, controlled study. 
High Alt Med Biol 2009, Ref 15 
   
Neurology Effect of high altitude on cognitive function Manuscript submitted 
   
Hematology Effect of high altitude on glomerular filtration rate Acta Physiol (Oxf). 2008 Mar;192(3):443-50 
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Table 2: Summary of Intraocular Pressure Measurements in Groups 1 and 2 at each examination 
height. All values are represented in mmHg. N - number of mountaineers, SD – one standard 
deviation. 
 
Group 1       
       
  N Mean SD Minimum Maximum 
 ZH 13 13.4 2.5 8.0 17.3 
 BC1 13 13.9 2.6 9.0 20.6 
 C1 13 14.7 2.4 10.6 19.6 
 C2 13 13.5 2.2 9.6 17.6 
       
       
Group 2       
       
  N Mean SD Minimum Maximum 
 ZH 12 12.8 3.4 6.3 21.0 
 BC1 12 13.9 3.2 8.3 20.3 
 C1 12 13.9 3.4 8.3 19.3 
 C2 12 13.2 2.4 8.6 18.3 
 BC2 12 12.3 3.0 7.6 19.3 
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Table 3: Oxygen saturation measurements (SaO2 in %) (mean ± standard deviation) and AMS-c 
scores [median and range (minimum-maximum)] in both groups at different altitudes. 
 
  ZH BC1 C1 C2 BC2 
       
Group 1 SaO2 98 ± 0.89 91 ± 8.31 79 ± 6.13 74 ± 7.79 87 ± 5.34 
 AMS-c 0 (0-0) 0.08 (0-0.88) 0.13 (0-1.15) 0.17 (0-2.42) 0 (0-0.18) 
       
Group 2 SaO2 98 ± 0.79 83 ± 2.69 74 ± 3.92 73 ± 4.52 N/A 
 AMS-c 0 (0-0) 0.04 (0-0.74) 0.09 (0-0.57) 0.08 (0-0.76) N/A 
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Figure legends 
Figure 1: Photograph of Mt. Muztagh Ata (7546m/24751ft) in Western Xinjiang Province, 
China. Inset: a climber having his fundus photographed in a high camp examination tent.  
 
Figure 2: Ascent profiles of both climbing groups on Mt Muztagh Ata. Examinations are marked 
by a « X ». Altitudes are shown in meters (m) and feet(ft) above sea level. 
 
Figure 3: Development of intraocular pressure in both groups. The combined values of both 
groups are normally distributed. Circles denote the mean, whiskers show the standard deviation 
of intraocular pressure at different altitudes. Brackets with asterisks (*) denote statistically 
significant differences.  
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